S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q3 2022

Avoro Capital Advisors

Period: Q3 2022 Β· Filed: 2022-11-14
View on SEC EDGAR β†—
AUM
$5.41B
Total portfolio value
Positions
39
Reported securities
Top Holding
APLS
12.8% $691.5M
QoQ Changes
+2 / -3
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
APLSAPELLIS PHARMACEUTICALS INC$691.5M12.78%$68.30β€”
12.8%
UTHRUNITED THERAPEUTICS CORP$612.8M11.32%$209.38$555.91+165.5%
11.3%
ARGXARGENX SE$446.8M8.25%$353.05$939.68+166.2%
8.3%
MRTXMIRATI THERAPEUTICS INC$387.6M7.16%β€”β€”
7.2%
SRPTSAREPTA THERAPEUTICS INC$351.0M6.48%$110.54$19.28-82.6%
6.5%
HZNPHORIZON THERAPEUTICS PLC$317.2M5.86%β€”β€”
5.9%
BMRNBIOMARIN PHARMACEUTICAL INC$301.4M5.57%$84.77$58.99-30.4%
5.6%
ASNDASCENDIS PHARMA$294.3M5.44%$103.26$274.50+165.8%
5.4%
FOLDAMICUS THERAPEUTICS INC$279.8M5.17%β€”β€”
5.2%
SGENSEAGEN INC$255.2M4.71%β€”β€”
4.7%
ALNYALNYLAM PHARMACEUTICALS INC$221.2M4.09%$200.16$312.78+56.3%
4.1%
XENEXENON PHARMACEUTICALS INC$176.9M3.27%$36.10$60.96+68.9%
3.3%
BCRXBIOCRYST PHARMACEUTICALS INC$114.0M2.11%$12.60$9.84-21.9%
2.1%
ISEEIVERIC BIO INC$105.8M1.96%β€”β€”
2.0%
MDGLMADRIGAL PHARMACEUTICALS INC$99.8M1.84%$64.99$528.10+712.6%
1.8%
KRYSKRYSTAL BIOTECH INC$88.9M1.64%$69.70$375.07+438.1%
1.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$86.4M1.60%$9.58$4.31-55.0%
1.6%
SNDXSYNDAX PHARMACEUTICALS INC$53.4M0.99%$24.03$21.82-9.2%
1.0%
MRSNMERSANA THERAPEUTICS INC$51.0M0.94%β€”β€”
0.9%
KURAKURA ONCOLOGY INC$48.1M0.89%$13.66$11.10-18.7%
0.9%
KYMRKYMERA THERAPEUTICS INC$47.2M0.87%$21.77$113.51+421.4%
0.9%
WHWKAADI BIOSCIENCES INC$40.3M0.74%$14.13$4.19-70.3%
0.7%
DSGNDESIGN THERAPEUTICS INC$37.2M0.69%$16.72$15.64-6.5%
0.7%
PMVPPMV PHARMACEUTICALS INC$36.4M0.67%$11.90$1.22-89.8%
0.7%
CBAYCYMABAY THERAPEUTICS INC$36.0M0.67%β€”β€”
0.7%
RAREULTRAGENYX PHARMACEUTICAL INC$31.1M0.57%$41.41$33.47-19.2%
0.6%
MNKDMANNKIND CORP$28.1M0.52%$3.09$4.52+46.3%
0.5%
GLUEMONTE ROSA THERAPEUTICS INC$27.5M0.51%$8.17$24.21+196.3%
0.5%
RNAMAVIDITY BIOSCIENCES INC$23.7M0.44%β€”β€”
0.4%
DICEDICE THERAPEUTICS INC$21.8M0.40%β€”β€”
0.4%

Quarter-on-Quarter Activity

Q3 2022 vs. Q2 2022

New Positions (2)

TickerIssuerNotional
AMLXAMYLYX PHARMACEUTICALS INC$18.3M
BCABBIOATLA INC$4.4M

Exited Positions (3)

TickerIssuerNotional
XBISPDR SERIES TRUST - S&P BIOTECH$66.8M
AMTIAPPLIED MOLECULAR TRANS INC$3.0M
GNCAGENOCEA BIOSCIENCES INC$0.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
KYMRKYMERA THERAPEUTICS INC$22.4M+72.2%+421.4%
WHWKAADI BIOSCIENCES INC$17.7M+55.8%-70.3%
BCRXBIOCRYST PHARMACEUTICALS INC$45.3M+39.2%-21.9%
ASNDASCENDIS PHARMA$82.8M+25.3%+165.8%
SGENSEAGEN INC$-14.7M+22.3%
KRYSKRYSTAL BIOTECH INC$18.3M+18.6%+438.1%
RNAMAVIDITY BIOSCIENCES INC$4.8M+11.5%
BMRNBIOMARIN PHARMACEUTICAL INC$29.3M+8.3%-30.4%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
KURAKURA ONCOLOGY INC$-39.8M-26.6%-18.7%
ALNYALNYLAM PHARMACEUTICALS INC$22.8M-18.8%+56.3%
ISEEIVERIC BIO INC$37.4M-17.1%
SRPTSAREPTA THERAPEUTICS INC$96.8M-6.3%-82.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$-15.4M-2.2%-55.0%
UTHRUNITED THERAPEUTICS CORP$-87.1M-1.5%+165.5%
PMVPPMV PHARMACEUTICALS INC$-7.8M-1.3%-89.8%
← Back to Hedge Funds